<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.114286</article-id><article-id pub-id-type="publisher-id">ACM-42008</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210400000_76198767.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  IDO在烟曲霉菌性角膜炎中的免疫调节作用
  Indoleamine 2,3-Dioxygenase Adjusts Immunization in Aspergillus Fumigatus Keratitis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>郭</surname><given-names>姝萱</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>姜</surname><given-names>楠</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>马</surname><given-names>静静</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>姜</surname><given-names>薇</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学，山东 青岛；青岛大学附属医院，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>04</month><year>2021</year></pub-date><volume>11</volume><issue>04</issue><fpage>1351</fpage><lpage>1360</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  吲哚胺2,3-双加氧酶(Indoleamine 2,3-dioxygenase, IDO)是一种具有免疫调节功能并参与色氨酸降解的限速酶，可以通过影响巨噬细胞作用调节炎症反应中的免疫应答，但IDO在烟曲霉菌性角膜炎中的其他免疫调节作用及机制仍不十分明了，因此，本实验在烟曲霉菌感染的小鼠模型及中性粒细胞模型上进行研究。方法：建立小鼠真菌性角膜炎动物模型，记录小鼠角膜炎症评分；采用RT-PCR检测烟曲霉菌菌丝刺激不同时间点的小鼠中性粒细胞中IDO、IDO下游因子AhR及炎症因子(TNF-α, IL-1β, IL-6, IL-10, IL-12) mRNA的表达。采用RT-PCR检测烟曲霉菌灭活菌丝刺激中性粒细胞16小时后各组炎症因子(IL-1β, TNF-α, IL-6) mRNA的表达变化。
   Indoleamine 2,3-dioxygenase (IDO) is a rate-limiting enzyme that functions as an immunomodulator and participates in the degradation of tryptophan. IDO can regulate the immune response of inflammation by affecting the action of macrophages. However, the immunomodulatory role and mechanism of IDO in Aspergillus fumigatus keratitis are still not very clear. Therefore, this study was conducted on the mouse model of Aspergillus fumigatus infection and the neutrophils model. METHODS: Animal models were developed to measure inflammatory scores and RT-PCR was used to detect the mRNA expression of IDO, downstream factors AHRs of IDO and inflammatory factors (TNF-α, IL-1β, IL-6, IL-10, IL-12) in the cornea of mice stimulated by Aspergillus niacae at different time points. RT-PCR was used to detect the mRNA expression of inflammatory factors (IL-1β, TNF-α, IL-6) in each group after 16 hours of stimulation by Aspergillus fumigatus inactivated hyphae.
 
</p></abstract><kwd-group><kwd>IDO，真菌性角膜炎，免疫调控, IDO</kwd><kwd> Aspergillus Fumigatus</kwd><kwd> Innate Immune</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>吲哚胺2,3-双加氧酶(Indoleamine 2,3-dioxygenase, IDO)是一种具有免疫调节功能并参与色氨酸降解的限速酶，可以通过影响巨噬细胞作用调节炎症反应中的免疫应答，但IDO在烟曲霉菌性角膜炎中的其他免疫调节作用及机制仍不十分明了，因此，本实验在烟曲霉菌感染的小鼠模型及中性粒细胞模型上进行研究。方法：建立小鼠真菌性角膜炎动物模型，记录小鼠角膜炎症评分；采用RT-PCR检测烟曲霉菌菌丝刺激不同时间点的小鼠中性粒细胞中IDO、IDO下游因子AhR及炎症因子(TNF-α, IL-1β, IL-6, IL-10, IL-12) mRNA的表达。采用RT-PCR检测烟曲霉菌灭活菌丝刺激中性粒细胞16小时后各组炎症因子(IL-1β, TNF-α, IL-6) mRNA的表达变化。</p></sec><sec id="s2"><title>关键词</title><p>IDO，真菌性角膜炎，免疫调控</p></sec><sec id="s3"><title>Indoleamine 2,3-Dioxygenase Adjusts Immunization in Aspergillus Fumigatus Keratitis</title><p>Shuxuan Guo<sup>1</sup><sup>,2</sup>, Nan Jiang<sup>1,2</sup>, Jingjing Ma<sup>1,2</sup>, Wei Jiang<sup>1,2</sup></p><p><sup>1</sup>Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/79-1572128x4_hanspub.png" /></p><p>Received: Mar. 25<sup>th</sup>, 2021; accepted: Apr. 20<sup>th</sup>, 2021; published: Apr. 27<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/79-1572128x5_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Indoleamine 2,3-dioxygenase (IDO) is a rate-limiting enzyme that functions as an immunomodulator and participates in the degradation of tryptophan. IDO can regulate the immune response of inflammation by affecting the action of macrophages. However, the immunomodulatory role and mechanism of IDO in Aspergillus fumigatus keratitis are still not very clear. Therefore, this study was conducted on the mouse model of Aspergillus fumigatus infection and the neutrophils model. METHODS: Animal models were developed to measure inflammatory scores and RT-PCR was used to detect the mRNA expression of IDO, downstream factors AHRs of IDO and inflammatory factors (TNF-α, IL-1β, IL-6, IL-10, IL-12) in the cornea of mice stimulated by Aspergillus niacae at different time points. RT-PCR was used to detect the mRNA expression of inflammatory factors (IL-1β, TNF-α, IL-6) in each group after 16 hours of stimulation by Aspergillus fumigatus inactivated hyphae.</p><p>Keywords:IDO, Aspergillus Fumigatus, Innate Immune</p><disp-formula id="hanspub.42008-formula79"><graphic xlink:href="//html.hanspub.org/file/79-1572128x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/79-1572128x7_hanspub.png" /> <img src="//html.hanspub.org/file/79-1572128x8_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>真菌性角膜炎(fungal keratitis, FK)是一种可以导致视力损害甚至失明的顽固性角膜炎。常见的致病菌包括镰刀菌、烟曲霉菌和念珠菌 [<xref ref-type="bibr" rid="hanspub.42008-ref1">1</xref>]。当烟曲霉菌侵入角膜后，烟曲霉菌所致的真菌性角膜炎便开始进展 [<xref ref-type="bibr" rid="hanspub.42008-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref3">3</xref>]。角膜上皮与基质层被烟曲霉菌感染后会出现一系列病变，例如角膜血管的扩张充血、一系列炎症因子招募大量炎症细胞至炎症部位。与此同时，角膜组织受到烟曲霉菌刺激后可以释放大量免疫活性物质，这些物质对于机体后续炎症及免疫反应至关重要 [<xref ref-type="bibr" rid="hanspub.42008-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref6">6</xref>]。</p><p>白细胞介素是参与真菌性角膜炎炎症反应及免疫调节的重要的促炎细胞因子，IL-1β、IL-6、IL-10、IL-12等细胞因子均在炎症反应中表达并进一步调控炎症反应的发展 [<xref ref-type="bibr" rid="hanspub.42008-ref7">7</xref>]。在真菌病原体的刺激下，IL-6诱导的信号通路被激活，进一步促进巨噬细胞和T-细胞趋化因子的分泌 [<xref ref-type="bibr" rid="hanspub.42008-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref9">9</xref>]。IL-1β作为炎症反应的“主力军”，可以通过Dectin-1、L0X-1等信号通路激活 [<xref ref-type="bibr" rid="hanspub.42008-ref10">10</xref>] 参与炎症反应。TNF-α作为具有广泛调节作用的细胞因子，在真菌性角膜炎中参与炎症反应并具有炎症调节作用 [<xref ref-type="bibr" rid="hanspub.42008-ref11">11</xref>]。吲哚胺2,3-双加氧酶(Indoleamine 2,3-dioxygenase, IDO)是一种参与色氨酸降解的限速酶，能够将色氨酸转化为犬尿氨酸并诱导对烟曲霉菌的免疫耐受 [<xref ref-type="bibr" rid="hanspub.42008-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref13">13</xref>]。IDO具有免疫调节剂的功能，有报道称，IDO可以通过抑制T-细胞相关免疫应答促进免疫耐受 [<xref ref-type="bibr" rid="hanspub.42008-ref14">14</xref>]。另外，IDO可以通过巨噬细胞调节炎症及免疫反应进程并维持免疫进程的平衡 [<xref ref-type="bibr" rid="hanspub.42008-ref15">15</xref>]，起到免疫保护作用，但IDO在中性粒细胞水平鲜少研究。</p><p>本研究将通过烟曲霉菌感染的动物模型及中性粒细胞模型，研究IDO在真菌性角膜炎中的免疫调控作用并研究IDO参与炎症反应的机制。</p></sec><sec id="s6"><title>2. 实验材料</title><sec id="s6_1"><title>2.1. 实验对象</title><sec id="s6_1_1"><title>2.1.1. 真菌菌种</title><p>编号为3.0772的标准烟曲霉菌菌株(中国普通微生物菌种保藏中心)。</p></sec><sec id="s6_1_2"><title>2.1.2. 实验动物</title><p>体重约为20 g的7周至8周龄健康C57BL/6雌性小鼠(济南鹏悦实验动物繁育有限公司)。</p></sec><sec id="s6_1_3"><title>2.1.3. 小鼠腹腔中性粒细胞</title><p>利用percoll法由小鼠腹腔中提取，具体方法见下文(2.3.5提取小鼠腹腔中性粒细胞)。</p></sec></sec><sec id="s6_2"><title>2.2. 试剂和耗材</title><sec id="s6_2_1"><title>2.2.1. 烟曲霉菌性角膜炎模型的建立</title><p>水合氯醛(10%)青岛大学附属医院，封口膜(制备角膜接触镜)上海三踏生物有限公司，外科5-0黑丝线 上海浦东金环医疗用品股份有限公司。</p></sec><sec id="s6_2_2"><title>2.2.2. 烟曲霉菌的培养</title><p>沙氏培养基 北京索莱宝公司。</p></sec><sec id="s6_2_3"><title>2.2.3. 中性粒细胞提取</title><p>酪蛋白 美国Sigma公司，DMEM培养基 美国Gibco公司。</p></sec><sec id="s6_2_4"><title>2.2.4. 动物和细胞实验预处理</title><p>1-甲基-DL-色氨酸(1-MT)美国Sigma公司。</p></sec><sec id="s6_2_5"><title>2.2.5. RT-PCR</title><p>RNA裂解液 大连TaKaRa公司，异丙醇分析纯 江苏强盛功能化学股份有限公司，逆转录试剂盒 南京挪威赞公司，氯仿分析纯 江苏强盛功能化学股份有限公司，SYBR 大连TaKaRa公司，DEPC水，上海生物工程有限公司，引物的设计与合成 大连TaKaRa公司。</p></sec></sec><sec id="s6_3"><title>2.3. 实验方法</title><sec id="s6_3_1"><title>2.3.1. 烟曲霉菌的培养与孢子、菌丝刺激液的制备</title><p>室温条件下，烟曲霉菌孢子接种于沙氏琼脂培养基，35℃孵育5天。在28℃的CO<sub>2</sub>恒温培养箱中培育7天。收取菌丝，置于摇床中，恒温37℃，120 rpm转速，进行3天到5天的培养并随时观察菌丝的形态，待菌丝为团块状时进行菌丝收集。研磨菌丝，制备烟曲霉菌菌液(1 &#215; 10<sup>8 </sup>CFU/ml)。4℃，4500 rpm转速条件下进行10分钟离心，离心后弃去上清液。在菌丝中加入75%乙醇，4℃存放8小时到16小时即可制备灭活菌丝。将灭活菌丝在4℃，4500 rpm转速条件下进行10分钟离心，离心后弃去上层酒精，使用无菌磷酸盐缓冲液清洗3遍，计数板计数，将浓度调整为1 &#215; 10<sup>8</sup> CFU/ml。</p></sec><sec id="s6_3_2"><title>2.3.2. 建立烟曲霉菌性角膜炎小鼠模型</title><p>将8%的水合氯醛注入小鼠腹腔片刻后即可对小鼠实施麻醉，用尖刀片刮除小鼠角膜的上皮层(约占角膜面积的1\2~2\3)后，再将烟曲霉活菌(1 &#215; 10<sup>8</sup> CFU/mL)涂抹在角膜中央的破损处，封口膜自制的小鼠角膜接触镜进行覆盖，缝合睑裂。使用裂隙灯显微镜观察小鼠角膜感染情况，处死小鼠后进行角膜收集。实验设计严格遵循实验动物使用的伦理准则，并获取伦理委员会批准。</p></sec><sec id="s6_3_3"><title>2.3.3. 小鼠角膜炎症评分</title><p>在烟曲霉菌性角膜炎小鼠模型建立后第三天，对各组小鼠的角膜炎症程度进行评级划分，将角膜溃疡面积、溃疡形态、混浊程度各分为I~IV级(1~4分)，总分为三项评分之和(0~12分)，评分原则如表1 [<xref ref-type="bibr" rid="hanspub.42008-ref16">16</xref>]。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Clinical score of keratiti</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >I级</th><th align="center" valign="middle" >II级</th><th align="center" valign="middle" >III级</th><th align="center" valign="middle" >IV级</th></tr></thead><tr><td align="center" valign="middle" >溃疡面积</td><td align="center" valign="middle" >1%~25%</td><td align="center" valign="middle" >26%~50%</td><td align="center" valign="middle" >51%~75%</td><td align="center" valign="middle" >76%~100%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >混浊程度</td><td align="center" valign="middle" >轻度混浊</td><td align="center" valign="middle" >较混浊</td><td align="center" valign="middle" >不均匀混浊</td><td align="center" valign="middle" >均匀、重度混浊</td></tr><tr><td align="center" valign="middle" >瞳孔可见</td><td align="center" valign="middle" >虹膜可见</td><td align="center" valign="middle" >虹膜不见</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >溃疡形态</td><td align="center" valign="middle" >不规则</td><td align="center" valign="middle" >轻度水肿</td><td align="center" valign="middle" >重度水肿，龛样溃疡或后弹力层膨出</td><td align="center" valign="middle" >穿孔或后弹力层膨出</td></tr></tbody></table></table-wrap><p>表1. 角膜炎临床炎症评分</p></sec><sec id="s6_3_4"><title>2.3.4. IDO抑制剂1-MT对动物模型的预处理</title><p>随机小鼠将分成两组，一组在建模前一天开始每天予以IDO特异性抑制剂1-MT (1 mg/ml)混悬液灌胃预处理，另一组给予等量PBS灌胃作为对照。每只小鼠的右眼构建烟曲霉菌性角膜炎的动物模型，左眼不予处理，在建模后第3天进行小鼠角膜收集，此时实验模型可分为四组：损伤对照组、1-MT组、感染组、1-MT + 感染组。随后，对收集的小鼠角膜进行RT-PCR实验。</p></sec><sec id="s6_3_5"><title>2.3.5. 小鼠腹腔提取中性粒细胞</title><p>1) 称重9 g酪蛋白溶于50 ml 0.1 mol/L的NaOH溶液，向C57BL/6小鼠的腹腔内注射1 ml酪蛋白溶液，间隔24小时后再次注射1 ml酪蛋白溶液，3小时后引颈处死小鼠并使用75%乙醇消毒。</p><p>2) 使用已消毒的剪刀纵向剪开小鼠腹部皮肤，确保腹膜完整。使用5 ml注射器吸取5 ml含10% FBS的DMEM培养液，注入小鼠腹腔并对腹腔进行按摩，保证中性粒细胞能被充分冲洗下来，为更加充分地冲洗，重复冲洗一次。</p><p>3) 培养液在4℃，2000 rpm转速条件下进行10分钟离心，倒掉上清，DMEM重悬细胞后用percoll法对中性粒细胞进行分离。加入适量含有10%FBS的DMEM重悬细胞混匀后，显微镜下计数，将细胞接种到12孔板中，在37℃培养箱中孵育2小时到3小时之后贴壁的即为中性粒细胞。</p></sec><sec id="s6_3_6"><title>2.3.6. 中性粒细胞的刺激实验</title><p>1) 将1-MT粉末溶于1 mM的NaOH中，再使用5 mM盐酸调整pH值到7.4，终浓度为50 mM，避光储存于4℃冰箱。其他试剂根据说明书进行溶解处理。</p><p>2) 加入IDO抑制剂1-MT (1 mM))预处理0.5小时。</p><p>3) 加入烟曲霉菌灭活菌丝(5 &#215; 10<sup>6</sup> CFU/ml)与中性粒细胞共培养，不同时间点(0小时、4小时、8小时、12小时、18小时、20小时、24小时)收取细胞进行RT-PCR实验。</p></sec><sec id="s6_3_7"><title>2.3.7. RT-PCR实验方法</title><p>1) 总RNA的提取</p><p>RNA裂解液收集小鼠腹腔中性粒细胞，裂解30分钟，12,000 rpm转速条件下进行5分钟离心，吸取上清液移入新的EP管中。将200 μl三氯甲烷加入上清液中，混匀后在室温条件下放置5分钟，待分层后再次在4℃，12,000 rpm转速条件下进行5分钟离心。完毕后可见样本分为三层，吸取上层RNA移入新的EP管中。加入相同体积的异丙醇，充分混匀后室温条件下放置10分钟。将样本第三次在4℃，12,000 rpm转速条件下进行10分钟离。去除上清液，将500 ml 75%的乙醇(由无水乙醇和DEPC水配置而成)沿管壁缓慢加入，充分混匀后在4℃，12,000 rpm转速条件下进行5分钟离心。室温条件下进行20分钟干燥。使用适量DEPC水溶解RNA，可储存于−80℃冰箱备用。</p><p>2) RNA浓度检测</p><p>吸取1 μl RNA，使用核酸蛋白分析仪对所有样本在260 nm/280 nm处的OD值(吸光度值)以及A260/280的比值进行分别测定。根据测得的RNA浓度计算2 μgRNA的样本溶液体积。</p><p>3) 逆转录反应</p><p>逆转录反应按照逆转录试剂盒说明书进行。</p><p>4) PCR反应</p><p>该反应重复40个循环(图1)，循环结束后记录循环数阈值结果。引物序列见表2。</p><p>图1. PCR反应条件</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Primer sequenc</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Gene</th><th align="center" valign="middle" >Primer sequence</th></tr></thead><tr><td align="center" valign="middle" >mβ-action</td><td align="center" valign="middle" >F:GATTACTGCTCTGGCTCCTAGC</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:GACTCATCGTACTCCTGCTTGC</td></tr><tr><td align="center" valign="middle" >mIL-1β</td><td align="center" valign="middle" >F:CGCAGCAGCACATCAACAAGAGC</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:TGTCCTCATCCTGGAAGGTCCACG</td></tr><tr><td align="center" valign="middle" >TNF-α</td><td align="center" valign="middle" >F:CCTGTAGCCCACGTCGTAG</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:GGGAGTAGACAAGGTACAACCC</td></tr><tr><td align="center" valign="middle" >mIL-6</td><td align="center" valign="middle" >F:CACAAGTCCGGAGAGGAGAC</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:CAGAATTGCCATTGCACAAC</td></tr><tr><td align="center" valign="middle" >mIDO</td><td align="center" valign="middle" >F:TCCTGGCAAACTGGAAGAAA</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:CACCAATAGAGAGACGAGGAAGAAG</td></tr><tr><td align="center" valign="middle" >mAhR</td><td align="center" valign="middle" >F:ATTGCCAAGTGCCAAATGGA</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:GGTTAAGTGTTCAGGTGCTGTAAGA</td></tr><tr><td align="center" valign="middle" >mIL-10</td><td align="center" valign="middle" >F:TGCTAACCGACTCCTTAATGCAGGAC</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:CCTTGATTTCTGGGCCATGCTTCTC</td></tr><tr><td align="center" valign="middle" >mIL-12</td><td align="center" valign="middle" >F:GGGACCAAACCAGCACATTG</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >R:TACCAAGGCACAGGGTCATCA</td></tr></tbody></table></table-wrap><p>表2. 引物序列</p></sec><sec id="s6_3_8"><title>2.3.8. 统计学处理</title><p>各个实验均独立操作，各组样本量n ≥ 6，至少重复操作三次。为了比较两组之间的差异，采用t检验来确定差异的显著性。数据以 x &#175; &#177; s 表示，采用Graphpad Prism 8.0软件，对各组结果进行统计学分析，以P &lt; 0.05为标准，差异具有统计学意义。</p></sec></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. IDO对烟曲霉菌性角膜炎的影响</title><p>首先，我们建立对照组、1-MT组、A.F.组、1-MT + A.F.组小鼠模型，感染烟曲霉菌后第3天在裂隙灯下观察各组小鼠的角膜感染情况。结果发现，A.F.组的角膜出现明显的炎症浸润和角膜水肿。与A.F.组相比，1-MT + A.F.组的炎症加重，临床评分更高，角膜溃疡更严重(图2，P &lt; 0.001)，对照组和1-MT组的角膜没有明显的角膜病变。</p><p>图2. IDO对小鼠烟曲霉菌性角膜炎进展及临床评分的影响</p><p>感染烟曲霉菌后第3天损伤对照组(Control)、1-MT组(1-MT)、感染组(A.F.)、1-MT + 感染组(1-MT + A.F.)的小鼠眼前节照相和角膜疾病反应临床评分</p></sec><sec id="s7_2"><title>3.2. IDO、下游因子AhR及炎症因子在烟曲霉菌感染的中性粒细胞中的表达</title><p>为了明确IDO、IDO下游因子AhR及炎症因子在中性粒细胞中的表达，我们建立烟曲霉菌感染的中性粒细胞中进行研究。结果显示IDO的mRNA在16 小时到达高峰图(图3(a)，P &lt; 0.05)，AhR mRNA表达水平在12~16小时达到高峰(图3(b)，P &lt; 0.05)，IL-1β、IL-6、IL-10mRNA表达水平在8小时达到高峰(图3(c)，图3(e)，图3(f)，P &lt; 0.05)，TNF-αmRNA表达水平在24小时最高(图3(d)，P &lt; 0.05)，IL-12mRNA表达水平在16小时达到高峰(图3(g)，P &lt; 0.05)。</p><p>正常组(Normal)和烟曲霉菌灭活菌丝刺激不同时间点后中性粒细胞IDO、AhR及炎症因子IL-1β、TNF-α、IL-6、IL-10、IL-12 mRNA的表达。</p><p>图3. IDO、AhR及炎症因子在烟曲霉菌感染的中性粒细胞中的表达</p></sec><sec id="s7_3"><title>3.3. IDO对烟曲霉菌感染的小鼠腹腔中性粒细胞中炎症因子表达的影响</title><p>为研究IDO对中性粒细胞炎症因子表达的影响，提取小鼠腹腔中性粒细胞，1-MT预处理0.5小时后应用烟曲霉菌灭活菌丝刺激细胞，分为正常组、A.F.、1-MT + A.F.组，小鼠腹腔中性粒细胞刺激16小时时，RT-PCR结果表明，IL-1β、TNF-α、IL-6在烟曲霉菌刺激中性粒细胞后表达上调，而应用1-MT处理中性粒细胞后，IL-1β、TNF-α、IL-6mRNA表达进一步上调(图4(a)~(c)，P &lt; 0.05)。</p><p>图4. IDO对烟曲霉菌感染的小鼠腹腔中性粒细胞炎症因子表达的影响</p><p>正常组、A.F.组、1-MT + A.F.组在16小时时小鼠腹腔中性粒细胞炎症因子IL-1β、TNF-α、IL-6mRNA的表达。</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>真菌性角膜炎是一种难治性角膜炎，可以导致严重的视力损害甚至失明。角膜炎发生时，角膜组织出现角膜水肿、溃疡，大量的炎症细胞因子聚集到溃疡部位，并伴有大量的免疫活性物质释放等显著的病理改变 [<xref ref-type="bibr" rid="hanspub.42008-ref17">17</xref>]。角膜组织受到烟曲霉菌刺激后释放出来的免疫活性物质对于清除病原体、维持角膜正常结构以及调节真菌性角膜炎炎症进程具有重要意义。适度的炎症反应可以加速病原体的杀灭，具有免疫保护作用，但过度的炎症反而会使病灶的炎症病变损伤加重 [<xref ref-type="bibr" rid="hanspub.42008-ref18">18</xref>]。</p><p>在烟曲霉菌菌丝感染角膜上皮及基质层之后，角膜组织会出现水肿、混浊及溃疡等症状，随之发生改变的是炎症细胞和细胞因子一系列的炎症免疫应答。IDO在炎症和自身免疫性疾病中发挥着重要作用。前期研究表明，IDO表达于小鼠角膜中，并可能参与了相关的炎症调节 [<xref ref-type="bibr" rid="hanspub.42008-ref19">19</xref>]。另外，在人角膜上皮细胞模型和巨噬细胞模型中，烟曲霉菌性感染进程中也有IDO的参与 [<xref ref-type="bibr" rid="hanspub.42008-ref20">20</xref>]。真菌病原体入侵角膜组织后，被模式识别受体(Toll样受体，包括TLR2和TLR4)识别，角膜炎症反应及免疫应答被激活 [<xref ref-type="bibr" rid="hanspub.42008-ref21">21</xref>]。在此过程中，被认为是炎症程度标志物的模式识别受体下游因子IL-1β、TNF-α、IL-6被激活，表达升高 [<xref ref-type="bibr" rid="hanspub.42008-ref22">22</xref>]。</p><p>为了明确烟曲霉菌性角膜炎炎症的进程以及IDO在此进程中发挥的调节作用，本实验建立了小鼠烟曲霉菌性角膜炎模型及中性粒细胞模型进行一系列研究。在体内实验研究中，我们发现，小鼠角膜经过烟曲霉菌感染后，角膜炎症病变明显，而IDO抑制后，小鼠烟曲霉菌性角膜炎炎症程度进一步加重，临床炎症评分明显增加。由此可知，IDO参与烟曲霉菌性角膜炎疾病进程并发挥免抑制炎症的免疫保护作用。</p><p>另外，我们建立了中性粒细胞感染的体外实验模型，通过PCR发现IDO在中性粒细胞中表达，其表达趋势与中性粒细胞相关炎症因子表达趋势一致，IDOmRNA的表达在16小时到达高峰，AhR mRNA表达水平在12~16小时达到高峰，IL-1β、IL-6、IL-10mRNA表达水平在8小时达到高峰，TNF-α mRNA表达水平在24小时最高，IL-12mRNA表达水平在16小时达到高峰。接下来，我们应用1-MT对小鼠中性粒细胞进行处理并用灭活烟曲霉菌菌丝刺激16小时，发现炎症因子IL-1β、TNF-α、IL-6在感染后表达上调，而加入IDO抑制剂后，炎症因子IL-1β、TNF-α、IL-6mRNA表达进一步上调。在机体炎症反应过程中，炎症因子起到“指挥官”的重要作用 [<xref ref-type="bibr" rid="hanspub.42008-ref23">23</xref>]。实验发现，在烟曲霉菌刺激的中性粒细胞中，IDO可以通过减少炎性细胞因子的释放从而产生炎症调节作用。有研究表明，IDO在代谢途径中，产生了L-犬尿氨酸代谢物，这种代谢物具有广泛的活性，使中性粒细胞的进一步激活受损，从而减少中性粒细胞相关炎症因子的表达 [<xref ref-type="bibr" rid="hanspub.42008-ref24">24</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref25">25</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref26">26</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref27">27</xref>]。另有研究表明，在人体肠炎模型中，NF-κB和MAPK途径受到病原体刺激后被激活，促进炎症因子IL-1β、TNF-α、IL-6的表达，而IDO代谢生成的L-犬尿氨酸能够抑制NF-κB通路 [<xref ref-type="bibr" rid="hanspub.42008-ref28">28</xref>] [<xref ref-type="bibr" rid="hanspub.42008-ref29">29</xref>]，减少促炎细胞因子IL-1β、TNF-α、IL-6的进一步表达和释放 [<xref ref-type="bibr" rid="hanspub.42008-ref30">30</xref>]，因此，IDO发挥了炎症反应和免疫调节的重要作用。</p></sec><sec id="s9"><title>5. 结论</title><p>总之，在烟曲霉菌性角膜炎中，IDO的抑制会导致烟曲霉菌感染加重。另外，IDO表达于中性粒细胞中，并通过减少炎症因子IL-1β、TNF-α、IL-6的释放减轻炎症反应，在烟曲霉菌性角膜炎疾病进程中起着重要作用，而IDO在烟曲霉菌性角膜炎愈后过程中的作用有待于进一步探讨，或许，IDO可以成为下一步炎症治疗的新靶点。</p></sec><sec id="s10"><title>文章引用</title><p>郭姝萱,姜 楠,马静静,姜 薇. IDO在烟曲霉菌性角膜炎中的免疫调节作用Indoleamine 2,3-Dioxygenase Adjusts Immunization in Aspergillus Fumigatus Keratitis[J]. 临床医学进展, 2021, 11(04): 1351-1360. https://doi.org/10.12677/ACM.2021.114286</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.42008-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Carvalho, A., Cunha, C., Bozza, S., et al. (2012) Immunity and Tolerance to Fungi in Hematopoietic Transplantation: Principles and Perspectives. Frontiers in Immunology, 3, 156.</mixed-citation></ref><ref id="hanspub.42008-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">De Luca, A., Bozza, S., Zelante, T., et al. (2010) Non-Hematopoietic Cells Contribute to Protective Tolerance to Aspergillus fumigatus via a TRIF Pathway Converging on IDO. Cellular &amp; Molecular Immunology, 7, 459-470.  
&lt;br&gt;https://doi.org/10.1038/cmi.2010.43</mixed-citation></ref><ref id="hanspub.42008-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Romani, L., Bistoni, F., Perruccio, K., et al. (2006) Thymosin Alpha1 Activates Dendritic Cell Tryptophan Catabolism and Establishes a Regulatory Environment for Balance of Inflammation and Tolerance. Blood, 108, 2265-2274.  
&lt;br&gt;https://doi.org/10.1182/blood-2006-02-004762</mixed-citation></ref><ref id="hanspub.42008-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Munn, D.H. and Mellor, A.L. (2013) Indoleamine 2,3 Dioxygenase and Metabolic Control of Immune Responses. Trends in Immunology, 34, 137-143. &lt;br&gt;https://doi.org/10.1016/j.it.2012.10.001</mixed-citation></ref><ref id="hanspub.42008-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mahmoudi, S., Masoomi, A., Ahmadikia, K., et al. (2018) Fungal Keratitis: An Overview of Clinical and Laboratory Aspects. Mycoses, 61, 916-930. &lt;br&gt;https://doi.org/10.1111/myc.12822</mixed-citation></ref><ref id="hanspub.42008-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Manikandan, P., Abdel-Hadi, A., Randhir Babu Singh, Y., Revathi, R., Anita, R., Banawas, S., Bin Dukhyil, A.A., Alshehri, B., Shobana, C.S., Panneer Selvam, K. and Narendran, V. (2019) Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of Fusarium and Aspergillus Isolates from Corneal Scrapings. BioMed Research International, 2019, Article ID: 6395840. &lt;br&gt;https://doi.org/10.1155/2019/6395840</mixed-citation></ref><ref id="hanspub.42008-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Tang, Q., Che, C., Lin, J., He, H., Zhao, W., Lv, L., Zhao, G., et al. (2019) Maresin1 Regulates Neutrophil Recruitment and IL-10 Expression in Aspergillus fumigatus Keratitis. International Immunopharmacology, 69, 103-108.  
&lt;br&gt;https://doi.org/10.1016/j.intimp.2019.01.032</mixed-citation></ref><ref id="hanspub.42008-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Wang, L., et al. (2015) Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method. Current Eye Research, 40, 1095-1101.  
&lt;br&gt;https://doi.org/10.3109/02713683.2015.1056802</mixed-citation></ref><ref id="hanspub.42008-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">He, D., et al. (2016) Etiological Analysis of Fungal Keratitis and Rapid Identification of Predominant Fungal Pathogens. Mycopathologia, 181, 75-82. &lt;br&gt;https://doi.org/10.1007/s11046-015-9950-x</mixed-citation></ref><ref id="hanspub.42008-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">El-Zaatari, M., Chang, Y.M., Zhang, M., et al. (2014) Tryptophan Catabolism Restricts IFN-γ-Expressing Neutrophils and Clostridium difficile Immunopathology. The Journal of Immunology, 193, 807-816.  
&lt;br&gt;https://doi.org/10.4049/jimmunol.1302913</mixed-citation></ref><ref id="hanspub.42008-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Loughman, J.A., Yarbrough, M.L., Tiemann Kristin, M., et al. (2016) Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli. Infection and Immunity, 84, 1176-1183.  
&lt;br&gt;https://doi.org/10.1128/IAI.01202-15</mixed-citation></ref><ref id="hanspub.42008-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Niu, Y., Zhao, G., Li, C., Lin, J., Jiang, N., Che, C., Zhang, J., Xu, Q., et al. (2018) Aspergillus fumigatus Increased PAR-2 Expression and Elevated Proinflammatory Cytokines Expression through the Pathway of PAR-2/ERK1/2 in Cornea. Investigative Ophthalmology &amp; Visual Science, 59, 166-175. &lt;br&gt;https://doi.org/10.1167/iovs.17-21887</mixed-citation></ref><ref id="hanspub.42008-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, J.Q., Li, C., Cui, C.X., Ma, Y.N., Zhao, G.Q., Peng, X.D., Xu, Q., Wang, Q., Zhu, G.Q., Li, C.Y., et al. (2019) Inhibition of LOX-1 Alleviates the Proinflammatory Effects of High-Mobility Group Box 1 in Aspergillus fumigatus Keratitis. International Journal of Ophthalmology, 12, 898-903. &lt;br&gt;https://doi.org/10.18240/ijo.2019.06.03</mixed-citation></ref><ref id="hanspub.42008-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wu, T.G., Wilhelmus, K.R. and Mitchell, B.M. (2003) Experimental Keratomycosis in a Mouse Model. Investigative Ophthalmology &amp; Visual Science, 44, 210-216. &lt;br&gt;https://doi.org/10.1167/iovs.02-0446</mixed-citation></ref><ref id="hanspub.42008-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Moreira-Teixeira, L., Stimpson, P.J., Stavropoulos, E., et al. (2020) Type I IFN Exacerbates Disease in Tuberculosis-Susceptible Mice by Inducing Neutrophil-Mediated Lung Inflammation and NETosis. Nature Communications, 11, Article No. 5566. &lt;br&gt;https://doi.org/10.1038/s41467-020-19412-6</mixed-citation></ref><ref id="hanspub.42008-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Pereira, S.A. and Livi, G.P. (1996) Aromatic Amino-Acid Biosynthesis in Candida albicans: Identification of the ARO4 Gene Encoding a Second DAHP Synthase. Current Genetics, 29, 441-445. &lt;br&gt;https://doi.org/10.1007/BF02221512</mixed-citation></ref><ref id="hanspub.42008-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, N., Zhao, G.Q., Lin, J., et al. (2016) Expression of Indoleamine 2,3-Dioxygenase in a Murine Model of Aspergillus fumigatus Keratitis. International Journal of Ophthalmology, 9, 491-496.</mixed-citation></ref><ref id="hanspub.42008-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, N., Zhao, G., Lin, J., et al. (2015) Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections. PLoS ONE, 10, e0137423.  
&lt;br&gt;https://doi.org/10.1371/journal.pone.0137423</mixed-citation></ref><ref id="hanspub.42008-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, N., Zhang, L., Zhao, G., et al. (2020) Indoleamine 2,3-Dioxygenase Regulates Macrophage Recruitment, Polarization and Phagocytosis in Aspergillus fumigatus Keratitis. Investigative Ophthalmology &amp; Visual Science, 61, 28.  
&lt;br&gt;https://doi.org/10.1167/iovs.61.8.28</mixed-citation></ref><ref id="hanspub.42008-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, G., Hu, M., Li, C., et al. (2018) Osteopontin Contributes to Effective Neutrophil Recruitment, IL-1β Production and Apoptosis in Aspergillus fumigatus Keratitis. Immunology &amp; Cell Biology, 96, 401-412.  
&lt;br&gt;https://doi.org/10.1111/imcb.12010</mixed-citation></ref><ref id="hanspub.42008-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Dickinson, C.M., LeBlanc, B.W., Edhi, M.M., et al. (2018) Leukadherin-1 Ameliorates Endothelial Barrier Damage Mediated by Neutrophils from Critically Ill Patients. Journal of Intensive Care, 6, Article No. 19.  
&lt;br&gt;https://doi.org/10.1186/s40560-018-0289-5</mixed-citation></ref><ref id="hanspub.42008-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., Jiang, N., Zhao, G., et al. (2020) Expression and Role of Aryl Hydrocarbon Receptor in Aspergillus fumigatus Keratitis. International Journal of Ophthalmology, 13, 199-205. &lt;br&gt;https://doi.org/10.18240/ijo.2020.02.01</mixed-citation></ref><ref id="hanspub.42008-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Liu, H., Liu, L., Fletcher, B.S., et al. (2006) Novel Action of Indoleamine 2,3-Dioxygenase Attenuating Acute Lung Allograft Injury. American Journal of Respiratory and Critical Care Medicine, 173, 566-72.  
&lt;br&gt;https://doi.org/10.1164/rccm.200509-1413OC</mixed-citation></ref><ref id="hanspub.42008-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Griffith, J.W., Sokol, C.L., Luster, A.D., et al. (2014) Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity. Annual Review of Immunology, 32, 659-702.  
&lt;br&gt;https://doi.org/10.1146/annurev-immunol-032713-120145</mixed-citation></ref><ref id="hanspub.42008-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Silva, R.L., Lopes, A.H., Guimarães, R.M., et al. (2017) CXCL1/CXCR2 Signaling in Pathological Pain: Role in Peripheral and Central Sensitization. Neurobiology of Disease, 105, 109-116. &lt;br&gt;https://doi.org/10.1016/j.nbd.2017.06.001</mixed-citation></ref><ref id="hanspub.42008-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Planagumà, A., Domènech, T., Pont, M., et al. (2015) Combined Anti CXC Receptors 1 and 2 Therapy Is a Promising Anti-Inflammatory Treatment for Respiratory Diseases by Reducing Neutrophil Migration and Activation. Pulmonary Pharmacology and Therapeutics, 34, 37-45. &lt;br&gt;https://doi.org/10.1016/j.pupt.2015.08.002</mixed-citation></ref><ref id="hanspub.42008-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Takaishi, M., Satoh, T., Akira, S., et al. (2018) Regnase-1, an Immunomodulator, Limits the IL-36/IL-36R Autostimulatory Loop in Keratinocytes to Suppress Skin Inflammation. Journal of Investigative Dermatology, 138, 1439-1442.  
&lt;br&gt;https://doi.org/10.1016/j.jid.2017.12.033</mixed-citation></ref><ref id="hanspub.42008-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Guo, J., Tu, J., Hu, Y., et al. (2019) Cathepsin G Cleaves and Activates IL-36 Gamma and Promotes the Inflammation of Psoriasis. Drug Design, Development and Therapy, 13, 581-588. &lt;br&gt;https://doi.org/10.2147/DDDT.S194765</mixed-citation></ref><ref id="hanspub.42008-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Degroote, R.L., Weigand, M., Hauck, S.M., et al. (2019) IL8 and PMA Trigger the Regulation of Different Biological Processes in Granulocyte Activation. Frontiers in Immunology, 10, 3064. &lt;br&gt;https://doi.org/10.3389/fimmu.2019.03064</mixed-citation></ref><ref id="hanspub.42008-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Renassia, C., Louis, S., Cuvellier, S., et al. (2020) Neutrophils from Hereditary Hemochromatosis Patients Are Protected from Iron Excess and Are Primed. Blood Advances, 4, 3853-3863.  
&lt;br&gt;https://doi.org/10.1182/bloodadvances.2020002198</mixed-citation></ref></ref-list></back></article>